Association between change in daily ambulatory activity and cardiovascular events in people with impaired glucose tolerance (NAVIGATOR trial): A cohort analysis

Background The extent to which change in physical activity can modify the risk of cardiovascular disease in individuals at high cardiovascular risk is uncertain. We investigated whether baseline and change in objectively-assessed ambulatory activity is associated with the risk of a cardiovascular ev...

Full description

Bibliographic Details
Main Authors: Yates, T, Haffner, S, Schulte, P, Thomas, L, Huffman, K, Bales, C, Califf, R, Holman, R, McMurray, J, Bethel, M, Tuomilehto, J, Davies, M, Kraus, W
Format: Journal article
Language:English
Published: Elsevier 2014
_version_ 1797089679830417408
author Yates, T
Haffner, S
Schulte, P
Thomas, L
Huffman, K
Bales, C
Califf, R
Holman, R
McMurray, J
Bethel, M
Tuomilehto, J
Davies, M
Kraus, W
author_facet Yates, T
Haffner, S
Schulte, P
Thomas, L
Huffman, K
Bales, C
Califf, R
Holman, R
McMurray, J
Bethel, M
Tuomilehto, J
Davies, M
Kraus, W
author_sort Yates, T
collection OXFORD
description Background The extent to which change in physical activity can modify the risk of cardiovascular disease in individuals at high cardiovascular risk is uncertain. We investigated whether baseline and change in objectively-assessed ambulatory activity is associated with the risk of a cardiovascular event in individuals at high cardiovascular risk with impaired glucose tolerance. Methods We assessed prospective data from the NAVIGATOR trial involving 9306 individuals with impaired glucose tolerance who were recruited in 40 countries between January, 2002, and January, 2004. Participants also either had existing cardiovascular disease (if age ≥50 years) or at least one additional cardiovascular risk factor (if age =55 years). Participants were followed-up for cardiovascular events (defi ned as cardiovascular mortality, non-fatal stroke, or myocardial infarction) for 6 years on average and had ambulatory activity assessed by pedometer at baseline and 12 months. Adjusted Cox proportional hazard models quantifi ed the association of baseline and change in ambulatory activity (from baseline to 12 months) with the risk of a subsequent cardiovascular event, after adjustment for each other and potential confounding variables. This study is registered with ClinicalTrials.gov NCT00097786. Findings During 45 211 person-years follow-up, 531 cardiovascular events occurred. Baseline ambulatory activity (hazard ratio [HR] per 2000 steps per day 0.90, 95% CI 0.84-0.96) and change in ambulatory activity (0.92, 0.86-0.99) were inversely associated with the risk of a cardiovascular event. Results for change in ambulatory activity were unaff ected when also adjusted for changes in body-mass index and other potential confounding variables at 12 months. Interpretation In individuals at high cardiovascular risk with impaired glucose tolerance, both baseline levels of daily ambulatory activity and change in ambulatory activity display a graded inverse association with the subsequent risk of a cardiovascular event. Funding Novartis Pharmaceuticals.
first_indexed 2024-03-07T03:07:32Z
format Journal article
id oxford-uuid:b30fb75a-fbc7-4efa-af40-aabe83656145
institution University of Oxford
language English
last_indexed 2024-03-07T03:07:32Z
publishDate 2014
publisher Elsevier
record_format dspace
spelling oxford-uuid:b30fb75a-fbc7-4efa-af40-aabe836561452022-03-27T04:16:18ZAssociation between change in daily ambulatory activity and cardiovascular events in people with impaired glucose tolerance (NAVIGATOR trial): A cohort analysisJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:b30fb75a-fbc7-4efa-af40-aabe83656145EnglishSymplectic Elements at OxfordElsevier2014Yates, THaffner, SSchulte, PThomas, LHuffman, KBales, CCaliff, RHolman, RMcMurray, JBethel, MTuomilehto, JDavies, MKraus, WBackground The extent to which change in physical activity can modify the risk of cardiovascular disease in individuals at high cardiovascular risk is uncertain. We investigated whether baseline and change in objectively-assessed ambulatory activity is associated with the risk of a cardiovascular event in individuals at high cardiovascular risk with impaired glucose tolerance. Methods We assessed prospective data from the NAVIGATOR trial involving 9306 individuals with impaired glucose tolerance who were recruited in 40 countries between January, 2002, and January, 2004. Participants also either had existing cardiovascular disease (if age ≥50 years) or at least one additional cardiovascular risk factor (if age =55 years). Participants were followed-up for cardiovascular events (defi ned as cardiovascular mortality, non-fatal stroke, or myocardial infarction) for 6 years on average and had ambulatory activity assessed by pedometer at baseline and 12 months. Adjusted Cox proportional hazard models quantifi ed the association of baseline and change in ambulatory activity (from baseline to 12 months) with the risk of a subsequent cardiovascular event, after adjustment for each other and potential confounding variables. This study is registered with ClinicalTrials.gov NCT00097786. Findings During 45 211 person-years follow-up, 531 cardiovascular events occurred. Baseline ambulatory activity (hazard ratio [HR] per 2000 steps per day 0.90, 95% CI 0.84-0.96) and change in ambulatory activity (0.92, 0.86-0.99) were inversely associated with the risk of a cardiovascular event. Results for change in ambulatory activity were unaff ected when also adjusted for changes in body-mass index and other potential confounding variables at 12 months. Interpretation In individuals at high cardiovascular risk with impaired glucose tolerance, both baseline levels of daily ambulatory activity and change in ambulatory activity display a graded inverse association with the subsequent risk of a cardiovascular event. Funding Novartis Pharmaceuticals.
spellingShingle Yates, T
Haffner, S
Schulte, P
Thomas, L
Huffman, K
Bales, C
Califf, R
Holman, R
McMurray, J
Bethel, M
Tuomilehto, J
Davies, M
Kraus, W
Association between change in daily ambulatory activity and cardiovascular events in people with impaired glucose tolerance (NAVIGATOR trial): A cohort analysis
title Association between change in daily ambulatory activity and cardiovascular events in people with impaired glucose tolerance (NAVIGATOR trial): A cohort analysis
title_full Association between change in daily ambulatory activity and cardiovascular events in people with impaired glucose tolerance (NAVIGATOR trial): A cohort analysis
title_fullStr Association between change in daily ambulatory activity and cardiovascular events in people with impaired glucose tolerance (NAVIGATOR trial): A cohort analysis
title_full_unstemmed Association between change in daily ambulatory activity and cardiovascular events in people with impaired glucose tolerance (NAVIGATOR trial): A cohort analysis
title_short Association between change in daily ambulatory activity and cardiovascular events in people with impaired glucose tolerance (NAVIGATOR trial): A cohort analysis
title_sort association between change in daily ambulatory activity and cardiovascular events in people with impaired glucose tolerance navigator trial a cohort analysis
work_keys_str_mv AT yatest associationbetweenchangeindailyambulatoryactivityandcardiovasculareventsinpeoplewithimpairedglucosetolerancenavigatortrialacohortanalysis
AT haffners associationbetweenchangeindailyambulatoryactivityandcardiovasculareventsinpeoplewithimpairedglucosetolerancenavigatortrialacohortanalysis
AT schultep associationbetweenchangeindailyambulatoryactivityandcardiovasculareventsinpeoplewithimpairedglucosetolerancenavigatortrialacohortanalysis
AT thomasl associationbetweenchangeindailyambulatoryactivityandcardiovasculareventsinpeoplewithimpairedglucosetolerancenavigatortrialacohortanalysis
AT huffmank associationbetweenchangeindailyambulatoryactivityandcardiovasculareventsinpeoplewithimpairedglucosetolerancenavigatortrialacohortanalysis
AT balesc associationbetweenchangeindailyambulatoryactivityandcardiovasculareventsinpeoplewithimpairedglucosetolerancenavigatortrialacohortanalysis
AT califfr associationbetweenchangeindailyambulatoryactivityandcardiovasculareventsinpeoplewithimpairedglucosetolerancenavigatortrialacohortanalysis
AT holmanr associationbetweenchangeindailyambulatoryactivityandcardiovasculareventsinpeoplewithimpairedglucosetolerancenavigatortrialacohortanalysis
AT mcmurrayj associationbetweenchangeindailyambulatoryactivityandcardiovasculareventsinpeoplewithimpairedglucosetolerancenavigatortrialacohortanalysis
AT bethelm associationbetweenchangeindailyambulatoryactivityandcardiovasculareventsinpeoplewithimpairedglucosetolerancenavigatortrialacohortanalysis
AT tuomilehtoj associationbetweenchangeindailyambulatoryactivityandcardiovasculareventsinpeoplewithimpairedglucosetolerancenavigatortrialacohortanalysis
AT daviesm associationbetweenchangeindailyambulatoryactivityandcardiovasculareventsinpeoplewithimpairedglucosetolerancenavigatortrialacohortanalysis
AT krausw associationbetweenchangeindailyambulatoryactivityandcardiovasculareventsinpeoplewithimpairedglucosetolerancenavigatortrialacohortanalysis